Indeed, EDA-FN has been demonstrated to facilitate tumor growth and invasiveness by promoting matrix stiffness, sustaining tumor-induced angiogenesis and lymphangiogenesis via VEGF-A165 (68) and VEGF-C, respectively (69). This evidence concerns the gene VEGFC and neoplasm.